Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Bachy

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Leukemia|October 7, 2025
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphomaDavid Vallois, Edoardo Missiaglia, Luis Veloza, et al.
Transplantation|February 9, 2021
Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort StudyThomas Barba, Emmanuel Bachy, Alizée Maarek, et al.
The Journal of Experimental Medicine|April 13, 2016
CD1d-restricted peripheral T cell lymphoma in mice and humansEmmanuel Bachy, Mirjam Urb, Shilpi Chandra, et al.
Oncotarget|July 27, 2016
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter studyEmilie Reboursiere, Fabien Le Bras, Charles Herbaux, et al.
Nature Medicine|September 22, 2022
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphomaEmmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, et al.
American Journal of Hematology|August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European centerPierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
Annals of Hematology|July 25, 2021
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter studyWon Seog Kim, Yasuhiro Oki, Seok Jin Kim, et al.
Leukemia|November 20, 2025
Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphomaDavid Vallois, Edoardo Missiaglia, Luis Veloza, et al.
Haematologica|June 16, 2022
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcomeLuis Veloza, Doriane Cavalieri, Edoardo Missiaglia, et al.
Leukemia|November 9, 2021
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma GroupAnne Mea Spanjaart, Per Ljungman, Rafael de La Camara, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Leukemia|October 7, 2025
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphomaDavid Vallois, Edoardo Missiaglia, Luis Veloza, et al.
Transplantation|February 9, 2021
Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort StudyThomas Barba, Emmanuel Bachy, Alizée Maarek, et al.
The Journal of Experimental Medicine|April 13, 2016
CD1d-restricted peripheral T cell lymphoma in mice and humansEmmanuel Bachy, Mirjam Urb, Shilpi Chandra, et al.
Oncotarget|July 27, 2016
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter studyEmilie Reboursiere, Fabien Le Bras, Charles Herbaux, et al.
Nature Medicine|September 22, 2022
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphomaEmmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, et al.
American Journal of Hematology|August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European centerPierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
Annals of Hematology|July 25, 2021
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter studyWon Seog Kim, Yasuhiro Oki, Seok Jin Kim, et al.
Leukemia|November 20, 2025
Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphomaDavid Vallois, Edoardo Missiaglia, Luis Veloza, et al.
Haematologica|June 16, 2022
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcomeLuis Veloza, Doriane Cavalieri, Edoardo Missiaglia, et al.
Leukemia|November 9, 2021
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma GroupAnne Mea Spanjaart, Per Ljungman, Rafael de La Camara, et al.
Pageof 18